Stay updated on NanoFlu Vaccine Safety & Immunogenicity Clinical Trial

Sign up to get notified when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:50:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site updates include adding Revision: v3.4.2 and removing older notices such as the funding/operating status message and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:49:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice informing users that information may not be up to date and guiding them to cc.nih.gov and opm.gov; updated the revision to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:41:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and updates the footer metadata to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; previously it displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T06:42:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added in place of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:46:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Locations section has been added, featuring North Carolina sites (Raleigh, Rocky Mount, Statesville) and the page revision updated to v3.3.3; the previous North Carolina Locations heading and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:15:20.000Z thumbnail image

Stay in the know with updates to NanoFlu Vaccine Safety & Immunogenicity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.